Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.58442 | 59 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.83708 | 64 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.84409 | 64 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 4.21162 | 68 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.37986 | 56 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.09562 | 43 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.33228 | 52 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.81669 | 64 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 4.46155 | 71 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.70711 | 62 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.76121 | 63 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.9295 | 65 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.96406 | 66 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.80453 | 64 |